Appraisal of physical health guidelines for severe mental illness
Nadia Friend A F , Jade Hughes B , Steve Kisely C D , Ratika Kumar E and Dan Siskind C D
+ Author Affiliations
- Author Affiliations
A Sunshine Coast Mental Health and Addiction Services, Maroochydore, Qld 4558, Australia.
B Metro North Mental Health Service, Royal Brisbane and Women’s Hospital, Herston, Qld 4029, Australia. Email: jade.p.hughes@gmail.com
C University of Queensland, School of Medicine, Brisbane, Qld 4102, Australia. Email: s.kisely@uq.edu.au; d.siskind@uq.edu.au
D Metro South Addiction and Mental Health Service, Brisbane, Qld 4102, Australia.
E The University of Newcastle, Faculty of Medicine and Public Health, University Drive, Callaghan, NSW 2308, Australia. Email: ratika.kumar@newcastle.edu.au
F Corresponding author. Email: nadia.friend@health.qld.gov.au
Australian Health Review 44(6) 904-915 https://doi.org/10.1071/AH20080
Submitted: 1 May 2020 Accepted: 15 June 2020 Published: 30 November 2020
Abstract
Objectives The aim of this study was to identify current physical health guidelines for severe mental illness (SMI) and appraise them using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument.
Methods Relevant research databases and grey literature were systematically searched to identify physical health guidelines for people with SMI. The grey literature was explored by web searches and targeted searches of the English websites of relevant peak bodies and government health agencies from Organisation for Economic Co-operation and Development countries. Included guidelines were independently appraised by two authors (NF and JH) using the AGREE II Instrument.
Results Of the 5352 records screened, 33 were assessed for eligibility. Fifteen practice guidelines met the inclusion criteria. The median domain scores as rated by the AGREE II Instrument ranged from 17% to 69%. The World Health Organization guideline, which demonstrated a broad range of clinical recommendations and sound methodological rigour, was rated the best.
Conclusions Most guidelines scored poorly when rated by the AGREE II Instrument. However, these guidelines may still be useful in assisting evidence-based clinical practice. The methodological rigour of future guidelines can be improved by ensuring the AGREE II domains are addressed during the development phase.
What is known about the topic? Compared with the general population, people with SMI experience greater chronic disease morbidity and mortality. There is limited evidence from randomised controlled trials to guide physical health care monitoring for people with SMI. Current guidelines and practice are largely based on expert consensus, clinical experience and good intentions.
What does this paper add? Using the AGREE II Instrument, this paper appraises the current physical health guidelines for people with SMI. The attributes of the guidelines examined included the evidence base, clarity of presentation, applicability in the real world, the involvement of stakeholders and conflicts of interest of various parties involved in guideline development.
What are the implications for practitioners? This review highlights the scarcity of high-quality and evidence-based guidelines for clinicians and researchers to address the physical health of people with SMI.
References
[1] Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013; 346 f2539| The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers.Crossref | GoogleScholarGoogle Scholar | 23694688PubMed |
[2] Firth J, Siddiqi N, Koyanagi A, Siskind D, Rosenbaum S, Galletly C, Allan S, Caneo C, Carney R, Carvalho AF, Chatterton ML, Correll CU, Curtis J, Gaughran F, Heald A, Hoare E, Jackson SE, Kisely S, Lovell K, McGorry PD, et al The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with severe mental illness. Lancet Psychiatry 2019; 6 675–712.
| The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with severe mental illness.Crossref | GoogleScholarGoogle Scholar | 31324560PubMed |
[3] American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27 596–601.
| Consensus development conference on antipsychotic drugs and obesity and diabetes.Crossref | GoogleScholarGoogle Scholar | 14747245PubMed |
[4] Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, De Hert M. Guideline Concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012; 42 125–47.
| Guideline Concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.Crossref | GoogleScholarGoogle Scholar | 21846426PubMed |
[5] Tosh G, Clifton AV, Xia J, White MM. Physical health care monitoring for people with serious mental illness. Cochrane Database Syst Rev 2014; 1 CD008298
| Physical health care monitoring for people with serious mental illness.Crossref | GoogleScholarGoogle Scholar |
[6] Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182 E839–42.
| AGREE II: advancing guideline development, reporting and evaluation in health care.Crossref | GoogleScholarGoogle Scholar | 20603348PubMed |
[7] Brouwers MC, Makarski J, Droucher LD, Levinson AJ. E-learning interventions are comparable to user’s manual in a randomized trial of training strategies for the AGREE II. Implement Sci 2011; 6 81
| E-learning interventions are comparable to user’s manual in a randomized trial of training strategies for the AGREE II.Crossref | GoogleScholarGoogle Scholar | 21791080PubMed |
[8] Sharma R, Alla K, Pfeffer D, Meurk C, Ford P, Kisely S, Gartner C. An appraisal of practice guidelines for smoking cessation in people with severe mental illness. Aust N Z J Psychiatry 2017; 51 1106–20.
| An appraisal of practice guidelines for smoking cessation in people with severe mental illness.Crossref | GoogleScholarGoogle Scholar | 28859486PubMed |
[9] Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, Himelhoch S, Fang B, Peterson E, Aquino PR, Keller W. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010; 36 71–93.
| The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.Crossref | GoogleScholarGoogle Scholar | 19955390PubMed |
[10] Harris B, Duggan M, Batterham P, Bartlem K, Clinton-McHarg T, Dunbar J, Fehily C, Lawrence D, Morgan M, Rosenbaum S. Australia’s mental and physical health tracker. Technical paper no. 06-2018. Melbourne: Australian Health Policy Collaboration; 2018. Available at: http://vuir.vu.edu.au/38748/1/australias-mental-and-physical-health-tracker-background-paper.pdf [verified 14 October 2020].
[11] Diabetes Canada Clinical Practice Guidelines Expert Committee; Lipscombe L, Booth G, Butalia S, Dasgupta K, Eurich DT, Goldenberg R, Khan N, MacCallum L, Shah BR, Simpson S. Pharmacologic glycemic management of type 2 diabetes in adults. Can J Diabetes 2018; 42 S88–103.
| Pharmacologic glycemic management of type 2 diabetes in adults.Crossref | GoogleScholarGoogle Scholar | 29650116PubMed |
[12] World Association of Family Doctors (WONCA). General principles for the management of physical health of people with a severe mental illness. n.d. Available at: https://equallywell.co.uk/wp-content/uploads/2018/09/General_Principles_-_WONCA-2.pdf [verified 17 October 2020].
[13] Sussex Partnership National Health Service Foundation Trust. Guidance on the use of antipsychotics version 4. 2018. Available at: https://www.sussexpartnership.nhs.uk/sites/default/files/documents/antipsychotic_guidelines_v4_-_apr_2018_-_final_3.pdf [verified 17 October 2020].
[14] Sernyak MJ. Implementation of monitoring and management guidelines for second-generation antipsychotics. J Clin Psychiatry 2007; 68 14–8.
| 17539695PubMed |
[15] National Health Service England. Improving physical healthcare for people living with severe mental illness (SMI) in primary care: guidance for CGCs. 2018. Available at: https://www.england.nhs.uk/wp-content/uploads/2018/02/improving-physical-health-care-for-smi-in-primary-care.pdf [ verified 17 October 2020].
[16] Working Group for Improving the Physical Health of People with SMI. Improving the physical health of adults with severe mental illness: essential actions. OP 100. London: Royal College of Psychiatrists; 2016. Available at: https://www.aomrc.org.uk/wp-content/uploads/2016/10/Improving_-physical_health_adults_with_SMI_essential_actions_251016-2.pdf [verified 14 October 2020].
[17] National Health Service England. Improving the physical health of people with serious mental illness: a practical toolkit. 2016. Available at: https://www.england.nhs.uk/mentalhealth/wp-content/uploads/sites/29/2016/05/serious-mental-hlth-toolkit-may16.pdf [verified 17 October 2020].
[18] Derbyshire Healthcare National Health Service Foundation Trust. Looking after mind and body: primary care toolkit – physical health checks for people with severe mental illness. 2011. Available at: https://www.derbyshirehealthcareft.nhs.uk/application/files/4415/4686/9590/Primary_Care_Toolkit_FINAL2.pdf [verified 17 October 2020].
[19] Government of South Australia. Metabolic health referral pathways. n.d. Available at: https://www.sahealth.sa.gov.au/wps/wcm/connect/b14cef004e4ad0bbae23fefefb3fa04f/metabolichealthreferralpathwaysflowchart-mhsa-ecmhs-20130124.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-b14cef004e4ad0bbae23fefefb3fa04f-niPFDtD [verified 17 October 2020].
[20] Royal College of Psychiatrists. Occasional paper 67: Physical health in mental health: final report of a scoping group. 2009. Available at: https://www.ucl.ac.uk/core-study/sites/core-study/files/18physical_mental.pdf [verified 17 October 2020].
[21] Shivers D, Rafi I, Cooper SRH. Positive cardiometabolic health resource: an intervention framework for patients with psychosis and schizophrenia. London: Royal College of Psychiatrists; 2014.
[22] McDevitt J. Primary care update for mental health nurses: evidence-based guidelines for nursing assessment, intervention, and follow up. J Psychosoc Nurs Ment Health Serv 2004; 42 22–35.
| Primary care update for mental health nurses: evidence-based guidelines for nursing assessment, intervention, and follow up.Crossref | GoogleScholarGoogle Scholar | 15540875PubMed |
[23] American Psychiatric Association. Psychiatry’s role in improving the physical health of patients with serious mental illness. 2017. Available at: http://www.psychiatry.org/File%20Library/Psychiatrists/Advocacy/psychiatrys-role-in-improving-the-physical-health-of-patients-with-serious-mental-illness.pdf [verified 17 October 2020].
[24] Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O, Tran N. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016; 50 410–72.
| Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Crossref | GoogleScholarGoogle Scholar | 27106681PubMed |
[25] Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ, WFSBP Task Force on Treatment Guidelines for Schizophrenia World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care. Int J Psychiatry Clin Pract 2017; 21 82–90.
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care.Crossref | GoogleScholarGoogle Scholar | 28498090PubMed |
[26] Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Möller HJ, WFSBP Task Force on Treatment Guidelines for Schizophrenia World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry 2013; 14 2–44.
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Crossref | GoogleScholarGoogle Scholar | 23216388PubMed |
[27] AGREE Next Steps Consortium. Appraisal of guidelines for research and evaluation II instrument. 2017. Available at: https://www.agreetrust.org/wp-content/uploads/2017/12/AGREE-II-Users-Manual-and-23-item-Instrument-2009-Update-2017.pdf [verified 17 October 2020].
[28] Siering U, Eikermann M, Hausner E, Hoffmann-Esser W, Neugebauer EA. Appraisal tools for clinical practice guidelines: a systematic review. PLoS One 2013; 8 e82915
| Appraisal tools for clinical practice guidelines: a systematic review.Crossref | GoogleScholarGoogle Scholar | 24349397PubMed |
[29] Armstrong JJ, Rodrigues IB, Wasiuta T, MacDermid JC. Quality assessment of osteoporosis clinical practice guidelines for physical activity and safe movement: an AGREE II appraisal. Arch Osteoporos 2016; 11 6
| Quality assessment of osteoporosis clinical practice guidelines for physical activity and safe movement: an AGREE II appraisal.Crossref | GoogleScholarGoogle Scholar | 26759266PubMed |
[30] Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Friedman A, Kleinberg D, Yevich SJ, et al Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161 1334–49.
| Physical health monitoring of patients with schizophrenia.Crossref | GoogleScholarGoogle Scholar | 15285957PubMed |
[31] Florida Medicaid Drug Therapy Management Program for Behavioural Health. Monitoring physical health and side-effects of psychotherapeutic medications in adults and children: an integrated approach. 2018. Available at: http://floridabhcenter.org/documents/2018PhysHealthGuidelines_9%20April%202018.pdf [verified 18 October 2020].
[32] Panagiotopoulos CDJ, Raghuram K. A physician handbook for metabolic monitoring for youth with mental illness treated with second-generation antipsychotics. Vancouver: BC Children’s Hospital; 2010. Available at: http://www.bcmhsus.ca/Documents/a-physician-handbook-for-metabolic-monitoring.pdf [verified 18 October 2020].
[33] Lambert TJ, Reavley NJ, Jorm AF, Oakley Browne MA. Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness. Aust N Z J Psychiatry 2017; 51 322–37.
| Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness.Crossref | GoogleScholarGoogle Scholar | 28343435PubMed |
[34] NSW Health. Physical health of mental health consumers. 2017. Available at: https://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2017_019.pdf [verified 18 October 2020].
[35] Orygen National Centre of Excellence in Youth Mental Health. Clinical practice in early psychosis: how to screen and intervene for positive cardiometabolic health. 2016. Available at: https://www.orygen.org.au/Campus/Expert-Network/Resources/Free/Clinical-Practice/How-to-screen-and-intervene-for-positive-cardiomet/Positive-cardiometabolic-health?ext= [verified 18 October 2020].
[36] Orygen National Centre of Excellence in Youth Mental Health. Clinical practice guide: physical and mental health: guidance, resources and tools for prevention and early intervention in cardiometabolic and sexual health issues. 2017. Available at: https://www.orygen.org.au/Training/Resources/Physical-and-sexual-health/Clinical-practice-points/Physical-mental-health/orygen_Clinical_practice_guide_Physical_sexual_hea?ext= [verified 18 October 2020].
[37] Stanley S, Laugharne J. Clinical guidelines for the physical care of mental health consumers. Perth: Community, Culture and Mental Health Unit, School of Psychiatry and Clinical Neurosciences, The University of Western Australia; 2010. Available at: https://www.chiefpsychiatrist.wa.gov.au/wp-content/uploads/2015/11/Clinical_Guidelines_Physical_Care_MH_Consumers_UWA.pdf [verified 18 October 2020].
[38] Cooper SJ, Reynolds GP, Barnes TRE, England E, Haddad PM, Heald A, Holt RIG, Lingford-Hughes A, Osborn D, McGowan O, Patel MX, Paton C, Reid P, Shiers D, Smith J. BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. J Psychopharmacol 2016; 30 717–48.
| BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.Crossref | GoogleScholarGoogle Scholar | 27147592PubMed |
[39] Nursing, Midwifery and Allied Health Professions Policy Unit, Quality Division, Strategy and External Relations Directorate. Improving the physical health of people with mental health problems: actions for mental health nurses. 2016. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/532253/JRA_Physical_Health_revised.pdf [verified 18 October 2020].
[40] De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, Newcomer JW, Uwakwe R, Asai I, Möller HJ, Gautam S, Detraux J, Correll CU. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10 138–51.
| Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Crossref | GoogleScholarGoogle Scholar | 21633691PubMed |
[41] De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Moller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 2009; 24 412–24.
| Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).Crossref | GoogleScholarGoogle Scholar | 19682863PubMed |
[42] Gothefors D, Adolfsson R, Attvall S, Erlinge D, Jarbin H, Lindström K, von Hausswolff-Juhlin YL, Morgell R, Toft E, Ösby U. Swedish clinical guidelines – prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry 2010; 64 294–302.
| Swedish clinical guidelines – prevention and management of metabolic risk in patients with severe psychiatric disorders.Crossref | GoogleScholarGoogle Scholar | 20662682PubMed |
[43] World Health Organization (WHO). Management of physical health conditions in adults with severe mental disorders. 2018. Available at: https://apps.who.int/iris/bitstream/handle/10665/275718/9789241550383-eng.pdf?ua=1 [verified 18 October 2020].
[44] Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013; 70 931–9.
| Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.Crossref | GoogleScholarGoogle Scholar | 23863861PubMed |
[45] Polus S, Lerberg P, Vogel J, Watananirun K, Souza JP, Mathai M, Gülmezoglu AM. Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool. PLoS One 2012; 7 e38891
| Appraisal of WHO guidelines in maternal health using the AGREE II assessment tool.Crossref | GoogleScholarGoogle Scholar | 22912662PubMed |
[46] Sabharwal S, Patel NK, Gauher S, Holloway I, Athanasiou T. High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument. Clin Orthop Relat Res 2014; 472 1982–8.
| High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument.Crossref | GoogleScholarGoogle Scholar | 24566890PubMed |
[47] Xie Z, Wang X, Sun L, Liu J, Guo Y, Xu B, Zhao L, Shen A. Appraisal of clinical practice guidelines on community-acquired pneumonia in children with AGREE II instrument. BMC Pediatr 2016; 16 119
| Appraisal of clinical practice guidelines on community-acquired pneumonia in children with AGREE II instrument.Crossref | GoogleScholarGoogle Scholar | 27484087PubMed |
[48] Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011; 343 d5621 . [Published correction appears in BMJ 2011; 343: d7063]
| Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.Crossref | GoogleScholarGoogle Scholar | 21990257PubMed |
[49] Papanikolaou GN, Baltogianni MS, Contopoulos-Ioannidis DG, Haidich AB, Giannakakis IA, Ioannidis JP. Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol 2001; 1 3
| Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions.Crossref | GoogleScholarGoogle Scholar | 11405896PubMed |
[50] World Health Organization (WHO). Package of essential noncommunicable (PEN) disease interventions for primary health care in low resource settings. 2010. Available at: https://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf [verified 18 October 2020].
[51] World Health Organization (WHO). Global strategy and action plan on ageing and health. 2017. Available at: https://www.who.int/ageing/WHO-GSAP-2017.pdf?ua=1 [verified 18 October 2020].
[52] Krahn GL, Fox MH. Health disparities of adults with intellectual disabilities: what do we know? What do we do? J Appl Res Intellect Disabil 2014; 27 431–46.
| Health disparities of adults with intellectual disabilities: what do we know? What do we do?Crossref | GoogleScholarGoogle Scholar | 23913632PubMed |
[53] Bond CJ, Singh D. More than a refresh required for closing the gap of Indigenous health inequality. Med J Aust 2020; 212 198–9e1.
| More than a refresh required for closing the gap of Indigenous health inequality.Crossref | GoogleScholarGoogle Scholar | 32030749PubMed |
